Erica Roberta Barbalho

Erica Roberta Barbalho

Auto-generated profile, based on publicly available information

Erica Roberta Barbalho

Universidade Federal do Rio Grande do Norte (UFRN), Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2019 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
EBErica Roberta Barbalho
Erica Roberta Barbalho
IRIlanna Marques Gomes da Rocha
Ilanna Marques Gomes da Rocha
GMGaltieri Medeiros
Galtieri Medeiros
RFRogerio Friedman
Rogerio Friedman
AFAna Paula Trussardi Fayh
Ana Paula Trussardi Fayh
Key words: Body composition; skeletal muscle mass; subcutaneous adipose tissue; visceral fat; imaging techniques

1 January 2024 in Radiologia Brasileira
Verified
Journal Article
Open access
PDF file
GMGaltieri Medeiros
Galtieri Medeiros
IRIlanna Marques Gomes da Rocha
Ilanna Marques Gomes da Rocha
AMAline Marcadenti
Aline Marcadenti
RBRicardo Andrade Bezerra
Ricardo Andrade Bezerra
EBErica Roberta Barbalho
Erica Roberta Barbalho
AFAna Paula Trussardi Fayh
Ana Paula Trussardi Fayh
Objective: This study evaluates the effects of sarcopenia and cachexia on the quality of life (QoL) of patients with gastrointestinal cancer during their initial cycle of chemotherapy, emphasizing the significance of computed tomography (CT) in assessing muscle mass. Materials and Methods: In this prospective study, we evaluated 60 adult patients with gastrointestinal cancer who started chemotherapy between January and December of 2017. Sarcopenia was diagnosed on the basis of CT findings, and QoL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Results: The mean age was 60.9 years, and 33 (55.0%) of the patients were men. Of the 60 patients, 33 (55.0%) had cachexia and 14 (23.3%) had sarcopenia. Chemotherapy significantly reduced QoL, particularly in the physical, role functioning, and social domains, with no differences between the cachexia and sarcopenia groups. Conclusion: Among patients with gastrointestinal cancer submitted to chemotherapy, the chemotherapy-induced decline in QoL does not seem to differ significantly between those with cachexia or sarcopenia, as classified by CT-measured muscle mass, and those without. However, CT-based muscle mass evaluation remains crucial for guiding customized intervention strategies. Integrating this evaluation in radiological reports can provide valuable insights for planning specific care, thus improving patient QoL during treatment.